Literature DB >> 34139234

Serum response factor deletion 5 regulates phospholamban phosphorylation and calcium uptake.

Kathleen C Woulfe1, Danielle A Jeffrey1, Julie Pires Da Silva1, Cortney E Wilson1, Jennifer H Mahaffey1, Edward Lau1, Dobromir Slavov1, Frehiwet Hailu1, Anis Karimpour-Fard2, Karen Dockstader1, Michael R Bristow1, Brian L Stauffer3, Shelley D Miyamoto4, Carmen C Sucharov5.   

Abstract

AIMS: Pediatric dilated cardiomyopathy (pDCM) is characterized by unique age-dependent molecular mechanisms that include myocellular responses to therapy. We previously showed that pDCM, but not adult DCM patients respond to phosphodiesterase 3 inhibitors (PDE3i) by increasing levels of the second messenger cAMP and consequent phosphorylation of phospholamban (PLN). However, the molecular mechanisms involved in the differential pediatric and adult response to PDE3i are not clear. METHODS AND
RESULTS: Quantification of serum response factor (SRF) isoforms from the left ventricle of explanted hearts showed that PDE3i treatment affects expression of SRF isoforms in pDCM hearts. An SRF isoform lacking exon 5 (SRFdel5) was highly expressed in the hearts of pediatric, but not adult DCM patients treated with PDE3i. To determine the functional consequence of expression of SRFdel5, we overexpressed full length SRF or SRFdel5 in cultured cardiomyocytes with and without adrenergic stimulation. Compared to a control adenovirus, expression of SRFdel5 increased phosphorylation of PLN, negatively affected expression of the phosphatase that promotes dephosphorylation of PLN (PP2Cε), and promoted faster calcium reuptake, whereas expression of full length SRF attenuated calcium reuptake through blunted phosphorylation of PLN.
CONCLUSIONS: Taken together, these data indicate that expression of SRFdel5 in pDCM hearts in response to PDE3i contributes to improved function through regulating PLN phosphorylation and thereby calcium reuptake.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium reuptake; Pediatric dilated cardiomyopathy; Phosphodiesterase 3 inhibition; Phospholamban; Serum response factor

Mesh:

Substances:

Year:  2021        PMID: 34139234      PMCID: PMC8546760          DOI: 10.1016/j.yjmcc.2021.06.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.763


  43 in total

1.  A role in learning for SRF: deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context.

Authors:  Amit Etkin; Juan Marcos Alarcón; Stuart P Weisberg; Khalid Touzani; Yan You Huang; Alfred Nordheim; Eric R Kandel
Journal:  Neuron       Date:  2006-04-06       Impact factor: 17.173

2.  SRF and SRFΔ5 Splicing Isoform Recruit Corepressor LSD1/KDM1A Modifying Structural Neuroplasticity and Environmental Stress Response.

Authors:  Laura Gerosa; Barbara Grillo; Chiara Forastieri; Alessandra Longaretti; Emanuela Toffolo; Alessandra Mallei; Silvia Bassani; Maurizio Popoli; Elena Battaglioli; Francesco Rusconi
Journal:  Mol Neurobiol       Date:  2020-01       Impact factor: 5.590

3.  Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes.

Authors:  Robert O Balza; Ravi P Misra
Journal:  J Biol Chem       Date:  2005-12-19       Impact factor: 5.157

4.  Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.

Authors:  Stephanie J Nakano; Shelley D Miyamoto; Matthew Movsesian; Penny Nelson; Brian L Stauffer; Carmen C Sucharov
Journal:  Circ Heart Fail       Date:  2014-10-02       Impact factor: 8.790

5.  Regulation of Ca2+ transport by cyclic 3',5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum.

Authors:  E G Kranias
Journal:  Biochim Biophys Acta       Date:  1985-02-21

6.  Pediatric dilated cardiomyopathy hearts display a unique gene expression profile.

Authors:  Philip D Tatman; Kathleen C Woulfe; Anis Karimpour-Fard; Danielle A Jeffrey; James Jaggers; Joseph C Cleveland; Karin Nunley; Matthew Rg Taylor; Shelley D Miyamoto; Brian L Stauffer; Carmen C Sucharov
Journal:  JCI Insight       Date:  2017-07-20

7.  Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.

Authors:  M Packer; N Medina; M Yushak
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

Review 8.  Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Authors:  Nelsa L Estrella; Francisco J Naya
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter.

Authors:  Carmen C Sucharov; Peter Mariner; Carlin Long; Michael Bristow; Leslie Leinwand
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

Review 10.  Biology of the cardiac myocyte in heart disease.

Authors:  Angela K Peter; Maureen A Bjerke; Leslie A Leinwand
Journal:  Mol Biol Cell       Date:  2016-07-15       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.